CD57 defines a functionally distinct population of mature NK cells in the human CD56dimCD16+ NK-cell subset

Sandra López‐Vergès(Cancer Research Institute), Jeffrey M. Milush(University of California, San Francisco), Suchitra Pandey(Blood Systems Research Institute), Vanessa A. York(University of California, San Francisco), Janice Arakawa‐Hoyt(Cancer Research Institute), Hanspeter Pircher(University of Freiburg), Philip J. Norris(University of California, San Francisco), Douglas F. Nixon(University of California, San Francisco), Lewis L. Lanier(Cancer Research Institute)
Blood
August 24, 2010
Cited by 733Open Access
Full Text

Abstract

Natural killer (NK) cells are innate immune lymphocytes that express a heterogeneous repertoire of germline-encoded receptors and undergo a distinct pattern of maturation. CD57 is a marker of terminal differentiation on human CD8(+) T cells. Very few newborn or fetal NK cells express CD57; however, the frequency of CD57-bearing NK cells increases with age. We assessed the transcriptional, phenotypic, and functional differences between CD57(+) and CD57(-) NK cells within the CD56(dim) mature NK subset. CD57(+) NK cells express a repertoire of NK-cell receptors, suggestive of a more mature phenotype, and proliferate less when stimulated with target cells and/or cytokines. By contrast, a higher frequency of CD57(+) NK cells produced interferon-γ and demonstrated more potent lytic activity when these cells were stimulated through the activating receptor CD16; however, they are less responsive to stimulation by interleukin-12 and interleukin-18. Finally, CD57 expression is induced on CD57(-)CD56(dim) NK cells after activation by interleukin-2. A combination of a mature phenotype, a higher cytotoxic capacity, a higher sensitivity to stimulation via CD16, with a decreased responsiveness to cytokines, and a decreased capacity to proliferate suggest that CD57(+) NK cells are highly mature and might be terminally differentiated.


Related Papers